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AbstrAct:
Psychoneuroimmunology has emerged as a broad interdisciplinary field examining the interaction 
between the psychological state, the nervous system, the endocrine system, and the immune system. 
Psychodermatology or psychocutaneous medicine is an intersection of psychiatry, psychology and 
dermatology. There is a growing awareness of the connection between psychosocial stress and somatic 
illnesses, including dermatological diseases. Psychosomatic factors are considered significant in more 
than a third of people suffering from skin diseases. Communication between the psyche and the skin 
is a complex interaction of psychological, immunologic and endocrine factors with the skin, involv-
ing a number of neuropeptides, interleukins and immune system mediators. The skin, being the 
largest organ of the body, is equipped with metabolic and endocrinological capacities that facilitate 
homeostatic control between internal and external environments. In addition to psychosocial stress, 
factors relevant for a psychoneuroimmunological approach to skin diseases include nutrition, gut 
and skin microbiota, sleep and circadian rhythm, physical activity, and orthomolecular medicine. 
Knowledge of psychoneuroimmunological mechanisms and factors relevant for a holistic approach 
is very important for a better and broader understanding of skin diseases, and for better therapeutic 
outcomes for patients.
Keywords: psychoneuroimmunology, psychodermatology, skin diseases, stress, psoriasis, atopic 
dermatitis
Sažetak:
Psihoneuroimunologija se pojavila kao široko interdisciplinarno područje koje obuhvaća povezanost psi-
hičkog stanja, živčanog sustava, endokrinološkog sustava i imunološkog sustava. Psihodermatologija ili 
psihokutana medicina područje je ispreplitanja psihijatrije, psihologije i dermatologije. Sve je veći broj 
spoznaja koja govore o vezi psihosocijalnog stresa i somatskih bolesti, uključujući dermatološke bolesti. 
Psihosomatski čimbenici smatraju se značajnima u više od trećine osoba oboljelih od kožnih bolesti. 
Komunikacija između psihe i kože uključuje složene interakcije između psiholoških, imunoloških i en-
dokrinoloških čimbenika sa kožnim sustavom, u čemu sudjeluje niz stvorenih neuropeptida, interleuki-
na i posrednika imunološkog sustava. Pritom je koža, kao najveći organ tijela, opremljena metaboličkim 
i endokrinološkim sposobnostima koje olakšavaju homeostatsku kontrolu između unutarnjih i vanjskih 
okruženja. Uz psihosocijalni stresa, čimbenici važni unutar psihoneuroimunološkog pristupa kožnim 
bolestima uključuju prehranu, mikrobiom crijeva i kože, spavanje i cirkadijalni ritam, fizičku aktivnost 
i ortomolekularnu medicinu. Poznavanje psihoneuroimunoloških mehanizama i čimbenika relevantnih 
za holistički pristup vrlo je važno zbog boljeg razumijevanje kožnih bolesti, a ujedno i za bolji terapijski 
ishod u bolesnika.
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introduction
The central nervous system, the endocrine system and the im-
mune system are very complex interrelated systems and are asso-
ciated with various diseases, including skin diseases. Psychoneu-
roimmunology (PNI) has emerged as a broad interdisciplinary 
field examining the interaction between psychological states, the 
nervous system, the endocrine system and the immune system. 
Findings in this field explain the biochemical contact between 
brain, behaviour and the immune system. The hypothalamic-pi-
tuitary-adrenal (HPA) axis and its constituents play a major role 
in these processes. Psychoneuroimmunology is attempting to 
explain which psychological states and in what way affect the 
immune system, and thus the health of an individual. All sorts of 
stressors (e.g. academic failure, bereavement or jumping a para-
chute) can change the immune response of an individual by in-
fluencing the aforementioned three systems. The communication 
between psyche and skin itself involves a complex psycho-im-
muno-endocrine-cutaneous interrelation, involving a number of 
neuropeptides, interleukins, and immune system mediators1.
The skin, the largest organ of the body, is equipped with metabolic 
and endocrine capacities that facilitate homeostatic control be-
tween internal and external factors. Many common dermatological 
diseases include some form of psychological influence on patho-
genic processes during illness, which can significantly contribute to 
the course and outcome of the disease2,3. There is also a relation-
ship between emotional stressors (acute or chronic), psychological/
psychiatric conditions and dermatoses such as psoriasis, atopic 
dermatitis, acne, alopecia, urticaria, HPV infections (e.g. viral 
warts), herpes simplex infection, vitiligo and prurigo4,5,6. The skin 
is inervated with a large network of sensory fibers and expresses 
many neurotransmitters and neuropeptide receptors that are also 
expressed by the central nervous system, including corticotro-
pin-releasing hormone (CRH), serotonin, prolactin and substance 
P7. Particularly important for communication between systems 
(including communication between skin and other systems) are 
cytokines that mediate communication between cells8. They also 
coordinate the development, maturation, and activity of cells of 
the immune system. The most common cytokins are interleukins2. 
Cytokines are the central elements of interaction between the 
immune system and behavior. Apart from local activity, they act 
globally on the whole organism. Proinflammatory cytokines affect 
tissue by stimulating the development of inflammatory reac-
tions and attract other immune cells involved in healing from 
injuries. In addition to local activity, proinflammatory cytokines 
coordinate a complex set of various reactions in the body to fight 
infections and injuries, including those in the skin. Cytokines 
also induce nonspecific endocrine responses by activating the 
sympathetic nervous system leading to release of catecholamines 
from plasma and activation of the HPA axis9. This leads to 
release of adrenocorticotropic hormone (ACTH) and glucocorti-
coids, especially stressful levels of cortisol. Cortisol is one of the 
most important factors and indicators of stress.
PSychological factorS, immune function and effectS on 
heAlth
In order for an organism to respond adequately to challenges and 
threats from the environment, there must exist a synchronised 
activation of psychological factors, the neuroendocrine system 
and the immune system. The generic psychoneuroimmuno-
logical model assumes that a stressful event triggers negative 
affective states. For example, people feel angry or sad in response 
to a stressful situation. Such emotions are accompanied by well 
known physiological changes such as changes in the autonom-
ic nervous system and the neuroendocrine system. Negative 
stress-induced emotions affect the immune system indirectly 
through the neuroendocrine system, and neuroendocrine and 
immune changes directly affect health outcomes, including 
course and outcome of ilness. However, studies have shown that 
stress can also directly affect the neuroendocrine system and im-
mune system, independently of emotions. Therefore, a modified 
psychoneuroimmunological model of stress was proposed which 
includes alternative relationships of stress with neuroendocrine 
and immune system. In the fields of psychoneuroimmunology 
and health psychology, there is growing interest in research that 
examines the mechanisms of the effects of psychological factors 
on immune functioning, health related behaviors, health out-
comes and course of illness. Among these factors, the most often 
examined are various stressful experiences, coping with stressful 
events, behaviors related to personality characteristics and behav-
iors resulting from negative affectrive states, which are significant 
in the psychoneuroneuomological approach to disease10.
Current research on the effects of stress on immune function 
suggest three potential mechanisms by which stress affects health 
and susceptibility to disease. These mechanisms include influ-
ence: (1) through the autonomic nervous system (sympathetic 
fibers descend from the brain directly into the lymphoid organs, 
releasing various substances that affect their function and thus 
ellicit an immune response); (2) through the endocrine system 
(psychological factors affect the HPA axis and sympathetic-ad-
renal-medullary (SAM) axis; various hormones are released that 
bind to leukocyte receptors and thus regulate their distribution 
and function); (3) through changes in health-related behaviors 
(during stress, worrying, turmoil, anxiety, depression, etc., people 
tend to engage in more health risk behaviors such as smoking, 
drinking alcohol, poor nutrition, inadequate sleeping habits, etc., 
which can exert an influence on the immune system and health 
outcomes)11,12. 
To properely assess these kind of influences on disease onset and 
exacerbation within the psychoneuroimmunological model, it is 
important to examine different types of stressful events, negative 
psychological experiences, mediating and moderating effects 
of coping, cognitive assessment or social support, measures of 
immune change and measures of health outcomes10.  One should 
bare in mind that psychneurouromological findings are often 
obtained on the basis of a small number of available immune 
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function indicators. Therefore, psychoneurimunological find-
ings regarding immune system outcomes (not health outcomes) 
can provide information on the interdependence of behavior, 
the central nervous system and the immune system, but do not 
necessarily indicate changes in disease suceptability11.
the relationShiP between PSyche and Skin
Psychodermatology or psychocutaneous medicine as an inter-
section of psychiatry, psychology and dermatology most often 
classyfies disorders in these categories: primarily psychiatric 
disorders, secondary psychiatric disorders and psychosomatic 
disorders.
Primarily psychiatric disorders are functional states without an 
obvious somatic pathophysiological basis, undoubtedly caused by 
psychogenic factors. They can manifest themselves on the skin, 
but the underlying cause is actually a psychiatric disorder or a 
behavior disorder with an immediate effect on the skin. Primarily 
psychiatric disorders with skin manifestations and signs are en-
countered in clinical practice less frequently than psychosomatic 
disorders. Examples of primary psychiatric disorders are artefact 
dermatitis (a condition in which a person injures his or her own 
skin) and trichotillomania (a condition in which a person pulls 
their own hair). People with obsessive-compulsive disorder can 
also cause skin self-injury. Delulusion of parasitosis is a form of 
psychotic disorder in which a person has delusional ideas about 
the existence of parasites in their skin and inflicts damage to the 
skin with the intention of removing the parasites13.
Secondary psychiatric disorders most commonly occur in 
chronic dermatological disorders such as alopecia, cystic acne, 
hemangioma, psoriasis, vitiligo, or gigantic congenital nevi. 
Coping with chronic illness (especially if the illness affects 
physical appearance and is perceived as unsightly) can result in 
a secondary psychiatric disorder in the form of a depressive or 
anxiety disorder, or cause symptoms of anxiety, depression, loss 
of self-esteem, feelings of social isolation and shame. These are 
reactive psychological states resulting from a primarily derma-
tological disorder. People suffering from skin diseases are often 
considered to be caontagious, dirty, and can be avoided by other 
people and discriminated against. Also, it is possible that a per-
son with a skin disease affecting visible areas of the skin cannot 
integrate the illness into his or her self-image, leading to possible 
psychological disturbances. The most common explanations for 
the high incidence of secondary psychiatric and psychological 
disorders are that (1) chronic skin disease causes many maladjust-
ments throughout life and affects social functioning; (2) visibility 
of skin diseases exposes a person to negative reactions from the 
social environment and stigmatization, thereby decreasing their 
self-esteem; (3) chronic illness causes strong anxiety, emotional 
instability and loss of self-confidence, leading to reduction in 
working ability and quality of life13. 
Psychosomatic disorders include dermatologic disorders whose 
onset end exacebation are influenced by stress. These disorders 
are associated with psychological and somatic causal factors that 
are jointly responsible for the onset, severity, exacerbation and 
duration of the disorder. Most commonly, there are signs of stress 
related exacerbation of symptoms regarding this category of psy-
chodermatological disorders, but rarely is there talk of stress as a 
causal factor. Considering skin disease in the context of Engel’s 
biopsychosocial model (by which health and disease are a result 
of interrelation between numerous biological, psychological and 
social factors) and the “diathesis-stress” model (by which the per-
son inherits the predisposition for the development of a disease 
that is activated by a stressful event), stress can be referred to as 
an etiological factor. This is consistent with reports from patients 
in clinical practice where patients often report stressful events 
that preceded the onset of the disease13,14.
the imPortance of PSychoneuroimmunological mechaniSmS 
in managing Skin diSeaSeS
Communication between psyche and skin is a complex interac-
tion of psychological, immunologic and endocrine factors with 
the skin, involving a number of neuropeptides, interleukins and 
immune system mediators. The skin, being the largest organ of 
the body, is equipped with metabolic and endocrinological ca-
pacities that facilitate homeostatic control between internal and 
external environments4.
There is a growing awareness of the connection between psy-
chosocial stress and somatic illnesses, including dermatological 
diseases. Psychosomatic factors are considered significant in more 
than a third of people suffering from skin diseases. Communi-
cation between psyche and skin involves psycho-neuro-endo-
crine-skin interactions involving brain, immune and skin activ-
ity. This communication encompasses different neuropeptides, 
interleukins, hormones and immune system mediators. There 
is clinical and experimental evidence that the brain can initiate, 
influence and/or stop biological skin events and that the skin (as 
an important part of the “diffuse brain”) can modify the quality 
of sensations and perception15.
The main neuroendocrinological and neural pathways of 
pathophysiological effect of psychological, biological and social 
factors on immunity and development of disease are the HPA 
axis, SAM axis, and sympathetic and parasympathetic nervous 
system. These systems react to stressogenic stimuli and can cause 
pathological events and illness in conditions of acute and chronic 
stress. In the context of skin and skin diseases, the neuroendo-
crine substances originate from the nerve fibers that inervate it, 
or from the skin cells that produce/excrete humoral signaling 
molecules (neurotransmitters, neuropeptides and hormones) that 
enter the HPA axis and correspond with neurotransmitters, neu-
ropeptides and hormones characteristic for that axis. Neurome-
diators produced in the skin include classical neurotransmitters 
(catecholamines and acetylcholine) produced and excreted from 
autonomic nerve fibers in skin and skin cells4.
Of all dermatoses, psoriasis is especially known as a disease 
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significantly influenced by psychological factors16. Internal 
factors such as inheritance and external factors such as trau-
ma, infections, skin flora, antigens, etc., are important in the 
pathogenesis of psoriasis. The disease sets on in a complex and 
dynamic interaction of genetic, environmental and immunolog-
ical factors. It is assumed that immune regulation plays a central 
pathophysiological role in the development of psoriasis. Various 
physiological and psychological consequences have been reported 
in patients with psoriasis, such as itch, sleep disturbances (up to 
80% of patients) and depression in patients with severe psoria-
sis (10-62%). Several psychoneuroimmunological mechanisms 
that can stimulate the onset of psoriasis have been established: 
sensory nerves release neuropeptides (neurotensin, somatostatin, 
supstance P and nerve growth factor (NGF)) which activate 
keratinocyte proliferation in the skin17,18. Sensory nerves and 
C-fibers also release the calcitonin gene-related peptide (CGRP) 
which directly activates keratinocyte proliferation and stimulates 
endothelial cells in the skin. Furthermore, C-fibers release nitric 
oxide, while cholinergic fibers produce acetylcholine and vasoac-
tive intestinal peptide (VIP) associated with vasodilation in the 
skin. Neuropeptides activate granulocytes and macrophages (via 
granulocyte-macrophage colony-stimulating factor, GM-CSF), 
attracting macrophages and monocytes which then excrete pros-
taglandin E2 (PGE2) and interleukin 10 (IL-10). In addition 
to increasing keratinocyte proliferation, these neurotransmitters 
stimulate T lymphocytes and vasodilation. In addition, the 
release of neurotransmitters is responsible for the appearance 
of Koebner’s phenomenon (which is typical for psoriasis and is 
caused by skin irritation)5.
The incurability and chronicity of psoriasis, its unpredictability 
characterised by flare-ups, lesions on visible areas of the skin, 
prevalence among young people and occurance of comorbid 
conditions are all factors that affect a persons physical and 
psychological health, working ability and productivity, social 
functioning and quality of life in general. People suffering from 
psoriasis and psoriatic arthritis often experience feelings of help-
lessness, anger and frustration. Social stigmatization and feelings 
of rejection are not uncommon. Patients often report having 
experienced some form of stigmatization in the past, hiding their 
health status from their social environment, colegues at work, 
friends and even family and report being percieved as contagious. 
Psoriasis, as well as numerous other dermatological diseases, can 
have a significant effect on relationships between the patient 
and his or her environment, which can manifest in symptom 
exacerbation and worsening of the functionality of the individual 
as a whole19. 
Due to psoriatic manifestations, patients often feel stigmatized 
and socially rejected which can lead to problems with self-image 
or self-esteem. Negative self-evaluation can lead to avoidance 
behaviours and social isolation, with negative implications for 
interpersonal relationships. Due to all of this, psoriasis can have 
a powerful impact on the quality of life and the psychological 
well-being of patients20. Research shows a high percentage of 
anxiety and depressive disorders in patients with psoriasis. The 
severity of disease correlates positively with depression and 
suicidal ideation13. Consequently, patients can experience high 
levels of stress that can exacerbate symptoms of psoriasis. Studies 
confirm this: daily stressors can act as triggers for symptom 
exacerbation, affecting treatment sucess and prolonging the time 
needed for recovery21,22. These findings can be interpreted from 
a psychoneuroimmunological perspective. Research suggests a 
disregulation in the HPA axis in a percentage of patients with 
psoriasis. A reduced glucocorticosteroid response to stressors, 
leading to insufficient immunosuppressive effects and maintain-
ance of an increased level of proinflammatory cytokines, could 
account for a stress-induced exacerbation of symptoms. Stress 
also affects the peripheral nervous system modulating the nerve 
cell and neuropeptide network in the skin. Immunohistological 
analyses show an increased number of nerve endings that release 
neuropeptides in psoriatic lesions compared to lesion-free skin 
and skin of healthy people. One of these neuropeptides, sub-
stance P, contributes to neurogenic inflammation by regulating 
proinflammatory cytokines20. In addition, psoriatic lesions con-
tain higher concentrations of neuropeptides that are also found 
in higher concentrations in the brain during stressful events13. 
The psychoneuroimmunologic perspectives is also complemented 
by research showing beneficial effects of psychological interven-
tions on the course of illness20.
Alongside psoriasis, atopic dermatitis and some other skin 
diseases are often associated with psychological and immune 
influences.
Atopic dermatitis is a common childhood disease, associat-
ed with immune disfunction, but also psychological factors. 
Although the exact etiology is not yet established, laboratory and 
clinical data point to a multifactorial pathogenesis that includes 
genetic and environmental factors. Psychological stress has 
been shown to be a trigger for symptom exacerbation in atopic 
dermatitis23,24,25. In patients with atopic dermatitis, immune 
responses by Th2 lymphocytic responses dominate, which is asso-
ciated with activation of keratinocytes, Langerhans cells, dermal 
dendritic cells, endothelial cells, mast cells, B lymphocytes and 
eosinophils. According to findings in the last decade, stress stim-
ulates the release of glucocorticoids that stimulate Th2 responses 
while inhibiting Th1 cellular responses26.. In addition, stress can 
cause a hyperacute response with accompanying activation of 
T lymphocytes and mast cells, impaired regulation of the HPA 
axis, expression and release of neurogenic inflammation media-
tors, and dysfunction of normal epidermal barrier function27. In 
addition to HPA axis disregulation, stress-induced neuroimune 
effects reslting in skin inflammation also involve additional 
peripheral effects, glucocorticoid function disregulation and 
glucocorticoid receptor dysfunction2.
Several nervous system mechanisms possibly responsible for 
the occurrence of itch have also been noted. Cholinergic fibers 
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release acetylcholine and produce VIP, leading to eosinophilic 
release of histamine and activation of peripheral itch receptors 
in the epidermis. The released histamine stimulates H2 and H3 
brain receptors and activates central nervous system neurons 
that secrete opioid peptides which also stimulate peripheral itch 
receptors. Moreover, C-type sensory nerve fibers are activated; 
neuropeptides, neurokinin A, substance P and NGF are released, 
activating itch receptors. Also, interleukin 2 (IL-2) and prosta-
glandins can indirectly stimulate itch receptors4.
Acne, characterised by very recognisable lesions, is also viewed 
through interaction between skin and hormonal, immunological 
and psychological factors28,29. There is evidence that stress may 
cause and exacerbate acne. Vice versa, skin lesions can have a 
psychosocial impact on the person and alter nervous system ac-
tivity. Both the peripheral and central nervous system have been 
shown to be associated with skin factors, with androgens being 
involved in the onset of the disease, formation of comedones 
and other manifestations30. Acne and seborrheic dermatitis may 
also occur due to neurogenic stimulation of sebaceous secretion 
mechanisms. Sensory nerves releases a variety of neuropeptides 
(neurotensin, somatostatin, substance P, NGF, melanocyte 
hormone and PPAR-) and proopiomelanocortin peptide which 
increase sebaceous gland secretion, thus contributing to the onset 
of the disease4. 
Alopecia areata is an autoimmune disease mediated by T and 
B lymphocytes with immunological responses to hair follicle 
antigens (trichohyalin and specific keratin)5,31. The condition is 
associated with the human leukocyte antigen (HLA) or immu-
nogenic and neuroendocrinological factors, with an important 
infuence of a number of factors, including psychological ones. 
During the immune reaction, autoantigens are recognised and 
reactions involving T lymphocytes and NK cells occur, leading to 
release of proinflammatory cytokines. Stress can have a negative 
effect on the disease as it prevents the production of ACTH, 
-MSH and ACTH releasing hormone, leading to damage of the 
hair follicle and alopecia. There are other psychoneuroimmuno-
logical mechanisms at work: the release of calcitonin gene-related 
peptide, CGRP (type C and sympathetic fibers), which stimu-
lates the immune response of Th1 lymphocyte and inhibits Th2 
lymphocytes31. Stimulation of B lymphocytes that produce IgG, 
along with the formation of an immune complex, and the activa-
tion of apoptosis in the hair follicle keratinocytes ultimately leads 
to alopecia. It is not uncommon for patients with alopecia areata 
to have adjustment and coping difficulties, anxiety or depression.
Vitiligo is a multifactorial polygenic disorder with a complex 
pathogenesis, linked with both genetic and non-genetic fac-
tors – autoimmune factors, nervous system factors, melanocyte 
structure and function disorders, disorder in defense against 
free oxygen radicals, decreased melanocyte viability, growth 
factor and cytokine deficiency. The role of stress has also been 
recognized. Studies show that stress can trigger vitiligo, with 
patients often reporting some form of significant emotional stress 
preceding the onset of the disease. Stress-induced exacerbation 
of autoimmune and inflammatory diseases is mediated through 
neurotransmitters and hormones. Stress causes catecholamine 
secretion by stimulation of the HPA axis. More specifically, stress 
can trigger the production and release of corticoliberin by the 
hypothalamus, which then stimulates the pituitary gland and 
the release of adrenocorticotrophin. The adrenal glands, then, 
synthesize catecholamines, which are cytotoxic to melanocytes, 
whose destruction is a characteristic of vitiligo32.
The above mentioned are some of the most prominent dermato-
ses associated with psychoneuroimmunological factors, knowl-
edge of which can be very important in clinical practice.
StreSS and Skin diSeaSeS
When reporting about being under stress, patients most often 
describe a state of difficult coping with the challenges from the 
environment and feeling tense and uncomfortable. Such expe-
riences are omnipresent and common to all people, so various 
theories and definitions of stress have emerged over the years. 
Various internal and external influences can disrupt the dynamic 
equilibrium of an organism: mechanical (injuries); physical (heat, 
noise, light); chemical (toxic materials); biological (infections); 
lack of food, water or sleep; difficulties in exchanging informa-
tion with the environment; difficulties in social interactions, 
danger and life-threatening situations. Such influences can lead 
to disordered homeostatic regulation of the organism. When 
the equilibrium cannot be restored by involuntary mobilization 
of biological resources or spontaneous behavioral changes, an 
alarm reaction is triggered within the body in the form of a stress 
reaction33.
Stress can be viewed as a process that includes stressors (physical-
ly or psychologically challenging events) and strain (physiological 
or psychological response o fan organism to stressors), with an 
emphasis on the relationship between the person and environ-
ment. This process involves continuous interactions and adjust-
ments called transactions, with the person and environment each 
affecting and being affected by the other. According to this view, 
stress is not just a stimulus or a response, but rather a process 
in which the person is an active agent who can influence the 
impact of a stressor through behavioral, cognitive and emotional 
strategies34.
Stress can also be defined as the circumstance in which transac-
tions lead a person to perceive a discrepancy between the physical 
or psychological demands of a situation and the resources of his 
or her biological, psychological, or social systems. Transactions 
in stress generally involve an assessment process called cogni-
tive appraisal, by which people assess two factors: (1) whether a 
demand threatens their physical or psychological well-being and 
(2) the resources available for meeting the demand. These are 
called primary and secondary appraisal35,36. Therefore, in order 
for a person to experience stress, the person must first appraise 
an environmental challenge  as threatening (primary appraisal). 
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But even if the challenge is appraised as threatening, it does not 
mean that it will be stressful if a person feels that it has sufficient 
resources for coping (secondary appraisal). When demands are 
appraised as greater than our resources, a person may experience 
a great deal of stress. Appraising events as stressful depends on 
two types of factors – those that relate to the person and thonse 
that relate to the situation. Personal factors include intellectual, 
motivational and personality characteristics. For example, people 
with high self-asteem are likely to believe they have the resources 
to meet demands that require the strenghts they posess. If they 
percieve an event as stressful, they may interpret it as a challenge 
rather than a threat. On the other hand, people who score high 
on perfectionism have a tendency to appraise even minor issues 
as potentially very stressful. Also, the more important a threat-
ened goal is, the more stress the person is likely to percieve. 
Regarding situatinal factors, events that involve very strong 
demands, that are immanent, ambiguous and are characterised 
by low controllability tend to be seen as more stressful34. 
Iti s important to have in mind the relationship between stress, 
the neuroendocrine system and disease. Physiological responses 
to stress and stress response control are mostly regulated by two 
components of the neuroendocrine system. These are the SAM 
and HPA axes. Both axes are associated with emotions, especially 
those related to stress. The SAM axis is sometimes referred to 
as the “fight-or-flight” or “strain” system, and the HPA axis as 
“distress” or “conservation-withdrawal” system. The first response 
to stress comes through the SAM axis, whose activity is strongly 
associated with acute emotions such as fear and anger. During 
stress the hypothalamus governs the transmission of sympathetic 
impulses to the bodily organs. It also stimulates the release of 
epinephrine, norepinephrine and other catecholamines into the 
bloodstream. During extreme stress and increased activation of 
the sympathetic system, the body is overwhelmed by epinephrine 
and norepinephrine, which increases the effects of sympathetic 
excitation even more. Through a feedback loop with the hypo-
thalamus, epinephrine increases ACTH secretion and thereby 
maintains increased excitation of the HPA axis. In response to 
the perception of stress and threat, the hypothalamus releases 
corticotrophin (CRH), whose central role in the stress process 
is the secretion of cortisol. CRH stimulates the frontal lobe of 
the pituitary gland, which releases adrenocorticotropic hormone 
(ACTH), beta-endorphin and prolactin. High levels of ACTH 
induce intense negative affective states. ACTH stimulates the 
adrenal gland cortex to increase glucocorticoid secretion, of 
which cortisol is the most important for stress. In order to restore 
system balance, glucocorticoids are released sometime later than 
epinephrine and norepinephrine. Cortisol provides the body 
with additional energy by increasing the concentration of amino 
acids in the blood, fatty acid secretion and glucose production 
from noncarbohydrates10,37. 
Stress also causes changes in the amount of neuropeptides re-
leased along with neurotransmitters, and through which neurons 
communicate with each other. Classical neurotransmitters such 
as norepinephrine and epinephrine are co-localized with various 
neuropeptides, including enkephalins, which suggests that neu-
ropeptides modulate tissue response to stress. There is evidence to 
indicate that individuals who exhibit high anxiety in potentially 
dangerous or uncomfortable situations have a higher serum level 
of substance P38. Cytokines also induce nonspecific endocrine 
responses by activating the sympathetic nervous system leading 
to release of catecholamines from plasma and activation of the 
HPA axis. This causes the release of ACTH and glucocorticoids, 
and especially stressful levels of cortisol10. 
The interaction between the central nervous system and the 
immune system can be seen through four pathways through 
which these two systems communicate bidirectionally: (1) the 
immune system signals the central nervous system by means of 
chemical mediators, i.e. cytokines; (2) the central nervous system 
regulates the immune response via HPA axis, (3) immune system 
cells have adrenaline receptors and (4) immune system organs are 
inervated by both branches of the autonomic nervous system, i.e. 
sympathetic and parasympathetic. This bidirectional communi-
cation opens up many possibilities for considering the connec-
tion between human behavior and the immune system10.
It is also important to mention the relationship between stress 
and immune function. The knowledge that components of the 
stress response affect immune function suggests that people’s 
behavior can affect changes in immune function. It is known 
that emotions and cognitions can alter the activity of important 
limbic structures, including the hippocampus and amygdala. 
These changes can signal the hippocampus to modify hormon-
al secretion of the adrenal gland and sympathetic responses 
of the autonomic nervous system. Adrenal and sympathetic 
components of the stress response have a powerful effect on 
the immune system. Lymphoid tissues (thymus, spleen, lymph 
nodes) receive signals from sympathetic and parasympathetic 
neurons. Changes in autonomic activity affect these tissues and 
alter the development and activity of lymphocytes. In this way, 
the cells needed for defense are directly influenced with auto-
nomic activity or changes in emotional states10. Lymphocytes 
have beta-adrenergic and cortisol receptors. The effects of cate-
cholamines on lymphocyte receptors are complex, i.e. they can 
increase and/or decrease indicators of immune system function-
ing. Meta-analyses of the relationship between psychosocial stress 
and immune function measures show that the impact of stress is 
not exclusively immunosuppressive - it depends on the dura-
tion and type of stressful event and individual characteristics38. 
For example, stimulation of beta-receptors by epinephrine can 
reduce the ability of NK cells to enter the lymph nodes, i.e. sites 
where they usually contact and neutralize antigens. At the same 
time, adrenaline can cause a contraction of the spleen, releasing 
stored lymphocytes into the bloostream, thereby increasing their 
ability to migrate to sites of infection. Beta-adrenergic activation, 
which accompanies acute stress, can increase the number of NK 
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cells in the bloodstream, but also reduce T-cells reproduction to 
appropriate stimuli10. During prolonged stress, phagocytosis is 
weakened, although the number of phagocytes in the peripheral 
blood increases. Chronic stress and depression are associated with 
increased neutrophils and elevated levels of proinflammatory 
cytokines in peripheral blood38. Therefore, instead of concluding 
that stress always inhibits immune system function, it is neces-
sary to analyze specific situations where elevation or reduction of 
immune function occurs.
The immune system also has important interactions with the 
HPA axis. Stressful cortisol levels can inhibit immune function 
in a number of ways, leading to a decrease in frequency and 
strength of the immune system signals and reduction in the 
number and activity of cells involved in the immune response. 
Unlike the effects of sympathetic activity and circulating epi-
nephrine, cortisol can cause very damaging effects on immune 
function. Therefore, it is important to be mindful of situations 
and emotional states that are associated with elevated levels of 
cortisol because they potentially degrade immune function and 
can have a role in development of disease. Also, immune cells 
such as T lymphocytes have receptors for a number of differ-
ent neurotransmitters. In this way, cells of the immune system 
receive signals from the nervous system, which affects their func-
tioning. One of the reasons why the link between neurotransmit-
ters and the immune system is important is the fact that negative 
emotional states (e.g. anxiety and depression) affect the activity 
of neurotransmitters10. Thus, stressful situations that lead to 
negative emotional experiences can affect the functioning of the 
immune system and potentially also dermatological diseases.
factorS relevant for a PSihoneuroimmunological aP-
Proach to Skin diSeaSeS
In managing a patient with skin disease, one of the factors worth 
condiering is nutrition, as well as the effect of non-adequate 
nutrition on dermatological disease within the psychoneuroim-
munological perspective39. For example, a patient may report of 
changes in nail or hair, which can be caused by lack of vitamins 
and minerals during disease or altered psychological state40. 
Sideropenic anemia, for example, can develop gradually during 
depression and related inadequate intake of vitamins or minerals, 
which can in turn be associated with the dermatological disease. 
In the clinical presentation, along with signs and symptoms 
typical for anemia, dermatological symptoms may also occur, in-
dicating a need for assesment of nutritinal habits of the patient. 
In cases of dermatological diseases associated with etiologically 
psychological disorders, treatment should target psychological 
segments along with dermatological ones.
Other dietary influences associated with the patient’s immune 
functioning and psychological state are also possible. For ex-
ample, iron may be important in patients with skin ulceration 
and wound (which are often chronic) or in patients with certain 
diseases (such as lupus erythematosus) that are associated with 
anemia of chronic diseases40 It is important to examine potential 
anemia in these dermatological diseases, especially in delayed 
healing of skin wounds, so that iron deficiency can be treated 
which ultimately effects the dermatological disease. Vitamin D is 
also important for the skin and can be associated with patient’s 
habits and conditions, which can in turn lead to deficiency41. 
In addition, other factors related to vitamin D, such as skin type 
(Fitzpatrick), gender, body mass index, physical activity, alco-
hol intake, and vitamin D receptor polymorphisms should be 
considered. Patients with dermatological diseases associated with 
photosensitivity who should avoid sun exposure and use photo-
protection are also at risk vitamin D deficiency41,42. 
The role of nutrition, microbiota, and orthomolecular medi-
cine has been particularly studied regarding psoriasis. The role 
of diet in the treatment of psoriasis has been studied for many 
years. Recent observation of comorbid conditions associated 
with psoriasis has stimulated interest in nutrition as a method 
for improving comorbid states occuring with the primary skin 
disease. There is a bidirectional connection between psoriasis and 
obesity. Obesity is associated with an increased incidence of pso-
riasis, severity of disease and a reduced response to conventional 
treatment. Weight loss, as a result of intervention with a tailored 
hypocaloric diet, can be beneficial for overweight or obese 
patients with psoriasis by resulting in a significant improvement 
in disease severity. Many epidemiological studies indicate that a 
Mediterranean diet offers beneficial effects on health, especially 
on cardiovascular, metabolic, neoplastic and chronic inflam-
matory diseases43. Recent data shows that there is a statistically 
significant correlation between adherence to a Mediterranean 
diet and the PASI score which describes the severity of psoriasis. 
Specifically, there were more psoriatic patients among those who 
did not adhere to a Mediteranean diet. The study also showed 
consumption of extra virgin olive oil and fish to be independent 
predictors of the PASI score and levels of C-reactive protein 
(CRP), the main protein of the acute phase of inflammation44. A 
tailored Mediteranean diet with high intake of monounsaturated 
fatty acids and omega-3 polyunsaturated acids, vegetables, fruits 
and fibers, along with limited intake of saturated fats, simple car-
bohydrates and sugars, is sugested as a nutritionist approach in 
psoriasis patients43. The gut and the skin are connected in a com-
plex way through what is called the ‘’gut-skin axis’’45. It appears 
that in patients with psoriasis the skin and intestinal microbiota 
is considerably modified, with a significantly reduced abun-
dance of Akkermansia muciniphilia when compared to healthy 
controls46. A randomized double-blind placebo-controlled trial 
showed that patients treated with a daily oral dose of bacterial 
strain Lactobacillus parcasei NCC2461 exhibited decreased skin 
sensitivity, accelerated barrier function recovery and preserve 
skin more efficiently after treatment with agents such as sodium 
lactate and urea47. The development of microbiota-targeted ther-
apy and its potential use for new diagnostic approaches to skin 
diseases is still in progress.
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Many patients with psoriasis use 
dietary supplements as a form of 
complementary medicine. The 
most commonly used are fish 
oil, selenium and zinc. Fish oil 
and omega-3 polyunsaturated 
fatty acids are the most common 
complementary supplements 
not only in psoriasis but also 
in patients with other derma-
tological diseases. An analysis 
of studies that examined fish 
oil supplementation has shown 
the effectiveness of fish oil in 
improving psoriasis symptoms if 
taken for a long time48. Al-
though zinc supplementation is common, the results on the the 
role of zinc in improving symptoms of psoriasis are inconclusive, 
with some studies showing positive effect, and some not43. Sele-
nium is an essential element with antiproliferative and immuno-
regulatory properties. Reduced serum levels of selenium are asso-
ciated with a more severe form of psoriasis. Studies have shown 
that selenium suplementation may be beneficial for those with 
altered serum levels of selenium, zinc, copper, total antioxidants 
and C-reactive protein49. A study using oral supplementation 
with a combination of micronutrients (folic acid, magnesium, 
iron, zinc, copper, manganese, selenium, chromium, iodine 
and vitamins A, D, E, K, C, B1, B2, B3, B6 and B12) during 3 
months in combination with a low dose of methotrexate showed 
a significant improvement in the severity of psoriasis50. 
Factors such as physical activity of the patient should also be 
considered, as well as the effect of this activity on the dermato-
logical disease within the psychoneuroimmunological model. 
This was especially investigated in psoriasis and atopic dermatitis. 
It is known that psoriasis can increase the risk of developing 
other chronic diseases such as cardiovascular diseases, type 2 
diabetes, obesity and metabolic syndrome. Physical activity is 
accepted as a vital component of prevention and treatment of 
cardiovascular diseases, type 2 diabetes, obesity and metabol-
ic syndrome, which is why many people recommend it as an 
important element of psoriasis management51. Although not 
much research has studied the relationship between physical 
activity and psoriasis, the existing associates a greater prevalence 
of psoriasis and psoriasis severity with a lack of physical activi-
ty. It has also been found that lack of physical activity can be a 
risk factor for psoriasis, while psoriasis may also be a risk factor 
for reduced physical activity52. Future research should focus on 
specific interventions regarding physical activity on randomized 
samples. Potential mechanisms by which physical activity could 
reduce psoriasis severity and cardiometabolic co-morbidities has 
been proposed: physical activity may affect psoriasis pathophysi-
ology via adipose tissue reductions and/or independent effects on 
inflammatory molecules, adhesion molecules, lipids and oxida-
tive stress. Some of these pathways may result from epigenetic 
changes such as DNA methylation, histone modifications, and 
RNA-associated gene silencing. Several of the pathways may 
overlap and flow bi-directionally, making an exact mapping of 
causative mechanisms challenging52. 
Nutrition is also an important factor in patients with atopic 
dermatitis. Evidence suggests excessive body weight is associated 
with atopic dermaitis41. Patients with atopic dermatitis have mul-
tiple potential risk factors for reduced physical activity. Some fea-
tures of the clinical presentation of atopic dermatitis contribute 
to this: patients with eczematous lesions on the hands and feet 
may have limited physical activity because of that; fatigue from 
sleep disturbances and depression may be indirectly associated 
with reduced physical activity; at the same time, heat, sweat and 
exercise are the most frequently reported circumstances leading 
to exacerbation of symptoms. Additionally, adult patients with 
atopic dermatitis, apart from reduced physical activity, also have 
significantly higher cardiovascular risk53,54,55.  
Effects of sleep and circadian rhythm are also factors that should 
be taken into consideration in a psychoneuroimmunological 
approach to patients with dermatological diseases. Current evi-
dence suggests that adequate sleep is very important for day-to-
day functioning and maintenance of health, supporting optimal 
physiological and psychological functioning. Moreover, disturbed 
sleep is known to cause pathological processes in the body. For 
example, persistent sleep disorder is a risk factor for future devel-
opment of diabetes, cardiovascular disease, hypertension and de-
pression56. Several studies have explored various domains of sleep 
in psoriasis patients. According to research literature, mood, 
obstructive sleep apnea, itching and pain are possible sources of 
sleep disorders56. Data also suggests that skin temperature, circa-
dian rhythm and psychological factors such as depression, affect 
the onset of itch, which leads to disturbed sleep57. Increased 
prevalence of obstructive sleep apnea and restless leg syndrome 
     Figure 1. Potential mechanisms by which physical activity could reduce psoriasis severity and cardiometabolic co-morbidities (from: 
     Wilson PB, Bohjanen KA, Ingraham SJ, Leon AS. Psoriasis and physical activity: a review. J Eur Acad Dermatol Venereol. 2012 
     Nov;26(11):1345-53.)
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in psoriasis patients has also been reported. Most studies have 
shown that sleep problems in psoriasis patients are related to 
itch, reduced mood and pain. It appears that itch is associated 
with increased sleep fragmentation, impaired sleep and decreased 
quality of sleep56. These findings are in line with research findings 
regarding other pruritic conditions. Reduced mood and pain are 
also associated with dysfunctional sleep as previously reported in 
healthy individuals and people with various other illnesses58. It 
is assumed that the interaction of reduced mood, pain and itch 
disrupts sleep, although the nature of this interaction requires a 
more detailed examination.
Significant experiences have also been observed in patients with 
atopic dermatitis. Intense itch (pruritus) during the night and 
the complex pathophysiology of atopic dermatitis can seriously 
affect sleep and become a major factor in the negative impact 
on the quality of life of a patient. Adults with atopic dermatitis 
often experience sleep disturbances, and data suggests that sleep 
quality worsens with the severity of atopic dermatitis. Itch and 
scratching significantly contributes to sleep disorders in children 
and adults with atopic dermatitis53,59. 
The circadian rhythm itself is a biological clock that controls a 
number of physiological functions throughout the body, includ-
ing various skin functions60. At the same time, skin cells express 
circadian “clock” genes, such as CLOCK (circadian locomotor 
output cycles coat), BMAL1 (brain and muscle aryl hydrocarbon 
receptor nuclear translocator-like protein 1), and Per1-3, which 
have autoregulatory feedback loops and maintain the rhythm of 
oscillating gene products. Studies have shown various skin physi-
ology that is attuned to a circadian rhythm, such as transepidermal 
water loss (TEWL), skin permeability, pH of skin surface and skin 
temperature.
The 24-hour daily cycle (driven by an endogenous brain clock) 
largely controls the daily rhythm of the skin, which is also 
modulated by external factors (including temperature, humidity, 
nutrition and stress). Circadian rhythm affects skin blood flow and 
skin barrier function (e.g. transepidermal water loss) and plays an 
important role in atopic dermatitis. There are even suggestions for 
the implementation of chronotherapy to improve the outcomes of 
treatment for patients with atopic dermatitis. It is suggested that 
sleep disturbances in patients with atopic dermatitis are predom-
inantly triggered by pruritus and scratching, although these are 
probably not the only etiological factors. Circadian rythms of 
cytokines, the immune system and skin physiology (e.g. transepi-
dermal water loss and blood flow to the skin) can also play an 
important role60. There are data suggesting that atopic dermatitis is 
associated with attention deficit hyperactivity disorder, emotional 
and behavioral problems and delayed growth, which is thought to 
be associated with disturbed sleep. Sleep disorders can have many 
negative consequences, including impaired neurocognitive func-
tion, more frequent behavioral problems and mood swings. The 
detection and treatment of these effects can be very useful in man-
aging and treating the primary dermatological disease. Along with 
the effects on the aforementioned cytokines and immune cells, 
circadian rhythm may also affect atopic dermatitis in a number of 
other ways, primarily by way of cortisol. Cortisol levels are highest 
in the morning, and then they gradually decrease and reach the 
lowest point in the evening, shortly after the onset of sleep. It is 
assumed that this daily variation of cortisol levels contributes to 
increased itch at night in patients with atopic dermatitis and other 
skin diseases, since the anti-inflammatory effect of cortisol is min-
imal at that time. Discontinuation of circadian cortisol rhythm in 
patients with atopic dermatitis was observed in studies, although 
there are no studies directly investigating the relationship between 
cortisol levels and sleep disturbances.
In addition, recent studies indicate that melatonin may play a role 
in sleep disorders of patients with atopic dermatitis59. Melatonin 
is a hormone secreted by the pineal gland, and is essential for 
regulating sleep and circadian rhythm. It is excreted at a dai-
ly rate: secretion increases shortly after the onset of nighttime, 
with a peak in the middle of the night (between 2:00 and 4:00 
AM), and gradualy declines during the second half of the night. 
Extrapineal melatonin has been found in multiple tissues such as 
skin, lymphocytes, mast cells, epithel of epithelial pathwyas, brain, 
retina, gastrointestinal tract and the reproductive tract. Various 
types of skin cells and lymphocytes produce melatonin and express 
melatonin receptors. Sleep is mostly in secondary focus in studies 
evaluating the treatment of atopic dermatitis, but several have 
evaluated treatment methods specifically aimed at improving sleep. 
There is currently no consensus on the treatment of sleep disorders 
in children with atopic dermatitis. First-generation antihistamines 
are most likely to be used due to their sedative effect, as they can 
cross the blood-brain barrier and affect the role of histamine in 
central nervous system excitation59.
Another important factor to consider is the microbiota and its 
effect on skin disease within the psychoneuroimmunological per-
spective27,61. The skin microbiota, and other microbiotas, such as 
the gut microbiota, play a key role in pathogenesis and progression 
of atopic dermatitis. The skin microbiota mostly refers to skin or-
ganisms that promote the normal functions of the immune system 
and prevent pathogen colonization. On the other hand, the gut 
microbiota can modulate immune, metabolic and neuroendocrine 
functions. Various interventions aimed at microbiota characteris-
tics are being developed to treat atopic dermatitis based on current 
research and underrstanding of the effects of microbiota on the 
onset of the disease27. 
Still, it is not clear whether changes in the microbiota are a result 
of skin damage or if changes in the microbiota induce skin barri-
er disfunction and inflammation. However, in atopic dermatitis, 
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communication between the microbiota and the immune system 
has been observed62. If, during early stages of life, it is altered, 
it can affect the maturation of innate and adaptive immunity. 
A new concept of posible influence on skin and gut microbiota 
modification (using hydrating agents containing unpathogenic 
biomass or probiotic supplements during early years of life) can 
be a preventive and therapeutic option in high-risk populations.
There is ample evidence supporting the view that the immune 
system is a key communication pathway between the gut and 
the brain, and that it plays an important role in stress-related 
psychopathology and represents a potential target for psychotro-
pic intervention63. Gut microbiota is a complex ecosystem with 
a variety of organisms and a sophisticated genomic structure. It 
contains microbes that produce antimicrobial peptides, short 
chain fatty acids and vitamins, as well as most conventional 
neurotransmitters of the human brain. It has been found that the 
microbiological contents of the gut play a key role in the devel-
opment of the immune system. Early interruption of reciprocal 
host-microbiota interaction may have lifelong consequences, not 
only in the function of the intestinal system but also in distal or-
gans, including the brain27. The immune system and the nervous 
system are in constant communication to maintain homeostasis.
Research on germ-free animals, testing of infectious diseases 
models, research of prebiotics, probiotics, and antibiotics have 
increased the understanding of this interaction. Particularly 
important is stress during early years of life, which can have a 
lifelong effect on the microbial contents of the intestine and 
permanently change the immune system. This early life stress 
may also affect psychopathology at a later age, which has, for a 
long time, been acknowledged in psychiatry. It is necessary to 
decipher completely the molecular mechanisms that connect 
the gut microbiota, the immune system and the central nervous 
system to a web of communication that influences patterns of 
behavior and psychopathology, in order to use the knowledge in 
the human condition, in health and disease. There is evidence 
pointing to key communication points where microbiological 
gut intervention (with medication, diet or perhaps transplan-
tation of fecal microbiota) can have a positive effect on mental 
health.
PSychological interventionS aS a form of adjuvant 
therApy
The psychoneuroimmunological perspectives is additionally com-
plemented by research aimed at examining the beneficial effects of 
psychological interventions such as counseling, psychoeducation, 
psychotherapy and mindfulness on the course of the illness, as a 
form of adjuvant therapy directed at stress reduction64. With the 
basic tenets of psychoneuroimmunology and the effects of stress 
on the neuroendocrine system in mind, it is important to consider 
the potential benefit of psychological interventions aimed at better 
coping with (chronic) disease, ovecoming challenges the disease 
places on the individual, working through emotional difficulties 
one might face, coping with stress and providing support so as to 
mitigate the effects of psychosocial stress on skin disease.
The effects of psychological intervention is especially being 
investigated in patients with psoriasis. In one study, psoriasis 
patients treated with phototherapy were divided into two groups: 
one group served as a control, and in this group, patients received 
standard phototherapy; while the second group listened to mind-
fulness based stress reduction tape recordings during phototherapy. 
Subjects who listened to stress-reduction tapes recovered signifi-
cantly faster than those that did not listen to the recordings65. The 
benefits of cognitive behavioral therapy have also been studied. In 
one study, the intervention group consisting of patients with pso-
riasis had been subjected to weekly sessions of cognitive behavioral 
therapy for a total duration of 6 weeks, with a focus on coping 
with symptoms of psoriasis along with standard medical treatment. 
After 6 weeks, patients in the therapy group showed significant 
reduction of symptoms of depression, anxiety and stress associated 
with psoriasis as well as the severity of the disease, compared to 
patients in the control group who received only standard treat-
ment. Interestingly, these improvements remained significant after 
a six-month follow-up66.
Valuable data has also been presented on the benefits of mindful-
ness-based cognitive therapy (MBCT), a hybrid method of the 
two above-mentioned interventions, which uses awareness-focus-
ing techniques to mitigate levels of physiological excitement and 
promotes effective mechamisms of coping with disease focused on 
acceptance. In a pilot study, the MBCT group showed significant 
improvements in the severity of disease and quality of life67. Re-
search also shows a beneficial effect of psychological interventions 
for patients with atopic dermatitis. Interventions such as autogen-
ic training, cognitive behavioral therapy, habit reversal training 
and stress reduction programs have been shown to be effective 
in reducing itch and scratching, and to also have a positive effect 
on anxiety, quality of life, and coping with stress64. Structured 
education programs for parents of children with atopic dermatitis 
have proven to be important for achieving the desirable health 
outcomes by providing knowledge and skills for better manage-
ment of disease and coping with challenges that atopic dermatitis 
presents for the patient and his or her family68.
concluSion
To conclude, knowledge of psychoneuroimmunology as a new 
interdisciplinary field and understanding of its mechanisms are 
very important for a better and broader understanding of skin 
diseases and for better therapeutic outcomes for  patients.
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